Shijiazhuang Yiling Pharmaceutical Co., Ltd. (02005) and Gushengtang (02273) have both reported their latest shareholder equity disclosures on September 17, 2026.

For Shijiazhuang Yiling Pharmaceutical (02005), the director Qu Jiguang increased his long position from 1.273 billion shares to 1.274 billion shares. This adjustment brings his stake to 43.16%, up slightly from the previously reported 43.13%.

In the case of Gushengtang (02273), Tu Zhiliang raised his long position from 82.1534 million shares to 82.1634 million shares. Consequently, his ownership percentage now stands at 35.06%, compared to the prior figure of 35.05%.

It is important to note that share count changes may be attributable to corporate actions such as rights issues, share consolidations, or stock splits. Investors are advised to verify the details against actual circumstances.